Company: BIAF
Filing Date: 2025-01-14
Form Type: 8-K
Source: 0001493152-25-002144
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-01-14
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.

On
January 10, 2025, the Compensation Committee approved an amendment (the “ Amendment”) to the employment agreement by and between
bioAffinity Technologies, Inc. (the “ Company”) and Maria Zannes, the Company’s Chief Executive Officer, to increase
the annual base salary payable to Ms. Zannes pursuant to her employment agreement with the Company to $300,0000. In addition, the Amendment
provides that the increase in base salary shall be retroactive to November 1, 2024.

The
foregoing description of the terms of the Amendment does not purport to be complete and is qualified in its entirety by reference to
the full text of the Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by
reference.